Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007

J Bigaard, C Stahlberg, M-B Jensen, Marianne Ewertz, N Kroman

    7 Citationer (Scopus)

    Abstract

    During the past 50 years, breast cancer incidence has increased by 2-3 % annually. Despite many years of testing for estrogen receptors (ER), evidence is scarce on breast cancer incidence by ER status. The aim of this paper was to investigate the increase in breast cancer incidence by ER status. Data were obtained from the clinical database of the Danish Breast Cancer Cooperative Group which holds nationwide data on diagnosis, including pathology, treatment, and follow-up on primary breast cancers since 1977. All Danish women
    OriginalsprogEngelsk
    TidsskriftBreast Cancer Research and Treatment
    Vol/bind136
    Udgave nummer2
    Sider (fra-til)559-64
    Antal sider6
    ISSN0167-6806
    DOI
    StatusUdgivet - nov. 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007'. Sammen danner de et unikt fingeraftryk.

    Citationsformater